• ESG Is Becoming a Clinical Operations Accountability

    Clinical Research News | Clinical operations leaders are being asked to deliver faster, more complex trials while carrying Environmental, Social, and Governance (ESG) commitments they do not directly control. That tension is no longer theoretical. As supplier sustainability performance becomes a material driver of execution risk, quality, and delivery speed, ESG is quietly shifting from a corporate reporting obligation to a clinical operations accountability.

    Jan 26, 2026

  • Why Clinical Trial Operations is the Place to Start with AI

    Clinical Research News | Clinical trials are foundational to all breakthrough therapies, yet they are mired in operational quicksand—particularly study startup inefficiencies. According to WCG’s 2025 Site Challenges Report, nearly one-third of respondents ranked study startup issues around contracts, budgets, and system builds as the leading problem slowing clinical trials while nearly 20% cite trial financial management (payments) as a topmost burden.

    Jan 23, 2026

  • How Smartwatches are Advancing Sleep Measurement

    Clinical Research News | Artificial intelligence (AI) is reshaping how clinical researchers study sleep, which has been tested with either simple self-reporting sleep logs or cumbersome sleep studies that take place in a lab or clinic. A new AI-driven sleep-staging framework called BIDSleep was developed at the University of Massachusetts Amherst.

    Jan 20, 2026

  • Closing the Research Gap in Africa Through Decentralized Patient Engagement and Remote Trial Models

    Clinical Research News | Africa remains one of the most important yet underleveraged regions in global drug development. The continent carries a substantial share of disease burden but contributes only a small fraction of clinical trial activity. This imbalance is not driven by scientific limitations or lack of patient interest. It reflects structural constraints that traditional site centric trial models have failed to overcome at scale.

    Jan 16, 2026

  • A Stronger, More Disciplined Future for Emerging Biopharma

    Clinical Research News | With the close of 2025 came the end of a prolonged biotech winter marked by reduced funding, massive job cuts, investor skepticism, and initial public offering slowdown. The experience, while painful, helped mature the biopharma industry with operational discipline and a new playbook for how to make the case with investors moving forward.

    Jan 13, 2026